FindMyRecallSubscribe
Class I: serious health riskOngoing

Amneal Pharmaceuticals Ropivacaine Hydrochloride Injection Recall

Ropivacaine Hydrochloride Injection, USP, 0

Amneal Pharmaceuticals, LLC · Bridgewater, NJ

Risk level
Class I
Reported by FDA
May 14, 2025
Recall ID
D-0402-2025
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled Ropivacaine Hydrochloride Injection starting Apr 17, 2025. The FDA classified it as Class I (serious health risk) and published enforcement report D-0402-2025 on May 14, 2025. Reason: Presence of Particulate Matter. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter

Product description

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

Lot numbers, UPCs & expiration codes

Lot #'s: AL240003, AL240004, Exp.: 01/31/2026

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0402-2025
Classification
Class I
Status
Ongoing
Recall initiated
Apr 17, 2025
FDA report date
May 14, 2025
Quantity
62 (12x100mL) bags
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0402-2025, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
96648
Address
400 Crossing Blvd Fl 3
Code information
Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
Postal code
08807-2863
Report date
May 14, 2025
Product type
Drugs
Recall number
D-0402-2025
Classification
Class I
Recalling firm
Amneal Pharmaceuticals, LLC
Product quantity
62 (12x100mL) bags
Reason for recall
Presence of Particulate Matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)
Distribution pattern
Nationwide in the US
Recall initiation date
Apr 17, 2025
Initial firm notification
Letter
Center classification date
May 5, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0402-2025, published May 14, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls